BPG is committed to discovery and dissemination of knowledge
Citation
Ma F, Zheng LY, Song DJ, Zhao ZW, Cao F, Hao WY, Qiu JQ, Lu D, Zheng JP. Regorafenib combined with programmed death inhibitor after initial treatment failure in unresectable hepatocellular carcinoma. World J Gastrointest Oncol 2026; 18(11): 123385 [DOI: 10.4251/wjgo.123385]
Please LOGIN to submit a new comment.